ORIC — ORIC PHARMACEUTICALS INC

Ownership history in DRIEHAUS CAPITAL MANAGEMENT LLC  ·  6 quarters on record

This page tracks every 13F SEC filing in which DRIEHAUS CAPITAL MANAGEMENT LLC reported a position in ORIC PHARMACEUTICALS INC (ORIC). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.02% (2024 Q1)
Avg. % of fund
0.01%
First filed
2023 Q3
Last filed
2025 Q3
Quarters held
6
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 148,778 +29,695 +24.9% 0.01% $1.8M $12.00
2024 Q3 REDUCED 119,083 -24,860 -17.3% 0.01% $1.2M $10.25
2024 Q2 UNCHANGED 143,943 — 0% 0.01% $1.0M $7.07
2024 Q1 UNCHANGED 143,943 — 0% 0.02% $2.0M $13.75
2 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    ORIC price (monthly, adj. close)

Other funds also holding ORIC

As of 2025 Q4 — sorted by position size

Column Group LLC 3Y 34.98% PFIZER INC 18.6% SR ONE CAPITAL MANAGEMENT, LP 3Y 5.34% EcoR1 Capital, LLC 3Y 7Y 2.5% VR Adviser, LLC 3Y 2.29% Euclidean Capital LLC 3Y 2.19% First Turn Management, LLC 1.88% NEA Management Company, LLC 3Y 7Y 1.72% MPM BioImpact LLC 3Y 1.68% SPHERA FUNDS MANAGEMENT LTD. 3Y 7Y 1.59%
← Back to DRIEHAUS CAPITAL MANAGEMENT LLC Holdings